Nuvation Bio, Inc. (NUVB)

NYSE: NUVB · IEX Real-Time Price · USD
2.69
+0.10 (3.86%)
Aug 10, 2022 4:00 PM EDT - Market closed

Total Valuation

Nuvation Bio has a market cap or net worth of $587.08 million. The enterprise value is -$112.03 million.

Market Cap 587.08M
Enterprise Value -112.03M

Important Dates

The latest earnings date was Wednesday, August 10, 2022, before market open.

Last Earnings Date Aug 10, 2022
Ex-Dividend Date n/a

Share Statistics

Nuvation Bio has 218.24 million shares outstanding. The number of shares has increased by 6.17% in one year.

Shares Outstanding 218.24M
Shares Change (YoY) +6.17%
Shares Change (QoQ) +1.50%
Owned by Insiders (%) 26.93%
Owned by Institutions (%) 76.80%
Float 112.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.85
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 33.58, with a Debt / Equity ratio of 0.01.

Current Ratio 33.58
Quick Ratio 33.08
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on equity (ROE) is -14.10% and return on invested capital (ROIC) is -18.00%.

Return on Equity (ROE) -14.10%
Return on Assets (ROA) -13.60%
Return on Capital (ROIC) -18.00%
Revenue Per Employee n/a
Profits Per Employee -$1.21M
Employee Count 85
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -67.51% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change -67.51%
50-Day Moving Average 3.33
200-Day Moving Average 4.49
Average Volume (30 Days) 1,172,143

Short Selling Information

The latest short interest is 9.53 million, so 4.37% of the outstanding shares have been sold short.

Short Interest 9.53M
Short % of Shares Out 4.37%
Short % of Float 8.46%
Short Ratio (days to cover) 7.12

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -118.46M
Net Income -103.26M
EBITDA -102.81M
EBIT -103.26M
Earnings Per Share (EPS) -$0.42
Full Income Statement

Balance Sheet

The company has $703.80 million in cash and $4.69 million in debt, giving a net cash position of $699.10 million or $3.20 per share.

Cash & Cash Equivalents 703.80M
Total Debt 4.69M
Net Cash 699.10M
Net Cash Per Share $3.20
Book Value 693.08M
Book Value Per Share 3.18
Working Capital 692.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$88.48 million and capital expenditures -$366,000, giving a free cash flow of -$88.84 million.

Operating Cash Flow -88.48M
Capital Expenditures -366,000
Free Cash Flow -88.84M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Nuvation Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -17.59%
FCF Yield -15.13%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -6.17%
Shareholder Yield -6.17%
Dividend Details

Analyst Forecast

The average price target for Nuvation Bio is $13.94, which is 418.22% higher than the current price. The consensus rating is "Buy".

Price Target $13.94
Price Target Difference 418.22%
Analyst Consensus Buy
Analyst Count 13
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a